Urinary cadmium concentrations and metabolic syndrome in U.S. adults: The National Health and Nutrition Examination Survey 2001–2014

Background: Low to moderate acute cadmium exposure has been associated with increased risk of chronic diseases, such as cardiovascular and kidney disease. Little is known about the association between urinary cadmium levels—an indicator of longer-term exposure—and metabolic syndrome (MetS). Methods:...

Full description

Bibliographic Details
Main Authors: Nudrat Noor, Geng Zong, Ellen W. Seely, Marc Weisskopf, Tamarra James-Todd
Format: Article
Language:English
Published: Elsevier 2018-12-01
Series:Environment International
Online Access:http://www.sciencedirect.com/science/article/pii/S0160412018302794
_version_ 1811266690200109056
author Nudrat Noor
Geng Zong
Ellen W. Seely
Marc Weisskopf
Tamarra James-Todd
author_facet Nudrat Noor
Geng Zong
Ellen W. Seely
Marc Weisskopf
Tamarra James-Todd
author_sort Nudrat Noor
collection DOAJ
description Background: Low to moderate acute cadmium exposure has been associated with increased risk of chronic diseases, such as cardiovascular and kidney disease. Little is known about the association between urinary cadmium levels—an indicator of longer-term exposure—and metabolic syndrome (MetS). Methods: We analysed data from 3982 participants aged 20–<80 years of the National Health and Nutrition Examination Survey 2001–2014. Urinary cadmium levels were measured and adjusted for creatinine using spot urine samples. Cadmium levels were evaluated in quintiles (Q). MetS was defined by National Cholesterol Education Program's Adult Treatment Panel III report criteria. Prevalence odds ratios (OR) and 95% confidence intervals (CI) were calculated using multivariable logistic regression accounting for complex survey design, while adjusting for potential confounders and stratifying by sex and smoking status. Results: In the overall study population, there was a marginal inverse association between urinary cadmium and MetS (adj. OR for Q5 versus Q1: 0.7; 95% CI: 0.5–1.0). Sex stratified models were similar. When examining individual components of MetS, participants with higher levels of urinary cadmium had decreased odds of abdominal obesity (adj. OR for Q5 versus Q1 0.4; 95% CI: 0.3–0.6), but increased odds for low HDL (adj. OR for Q5 versus Q1 2.1; 95% CI: 1.4–3.1). Among current smokers, higher urinary cadmium was associated with increased odds of MetS, hypertension, and low HDL even after accounting for serum cotinine—a marker of smoking intensity. Conclusions: Higher levels of urinary cadmium, a marker of long term exposure, were not associated with an increased risk of MetS in the overall study population. However, higher urine cadmium was associated with altered MetS components. Current smokers were the most vulnerable group, with higher long-term cadmium exposure being associated with increased risk of MetS, low HDL, and hypertension. Keywords: Cadmium, Metabolic syndrome, Obesity, Lipids, Hypertension, Hyperglycemia
first_indexed 2024-04-12T20:47:48Z
format Article
id doaj.art-16750060a6b44aa7b7acd1458c01f836
institution Directory Open Access Journal
issn 0160-4120
language English
last_indexed 2024-04-12T20:47:48Z
publishDate 2018-12-01
publisher Elsevier
record_format Article
series Environment International
spelling doaj.art-16750060a6b44aa7b7acd1458c01f8362022-12-22T03:17:12ZengElsevierEnvironment International0160-41202018-12-01121349356Urinary cadmium concentrations and metabolic syndrome in U.S. adults: The National Health and Nutrition Examination Survey 2001–2014Nudrat Noor0Geng Zong1Ellen W. Seely2Marc Weisskopf3Tamarra James-Todd4Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, United States of AmericaDepartment of Nutrition, Harvard School of Public Health, Boston, MA 02115, United States of AmericaDivision of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Ave., 3rd Floor, Boston, MA 02115, United States of AmericaDepartment of Environmental Health, Harvard School of Public Health, Boston, MA 02115, United States of America; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, United States of AmericaDepartment of Environmental Health, Harvard School of Public Health, Boston, MA 02115, United States of America; Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, United States of America; Division of Women's Health, Department of Medicine, Connors Center for Women's Health and Gender Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, United States of America; Corresponding author at: Department of Environmental Health, Harvard T.H. Chan School of Public Health, 665 Huntington Ave., Bldg. 1, 14th Floor, Boston, MA 02120, United States of America.Background: Low to moderate acute cadmium exposure has been associated with increased risk of chronic diseases, such as cardiovascular and kidney disease. Little is known about the association between urinary cadmium levels—an indicator of longer-term exposure—and metabolic syndrome (MetS). Methods: We analysed data from 3982 participants aged 20–<80 years of the National Health and Nutrition Examination Survey 2001–2014. Urinary cadmium levels were measured and adjusted for creatinine using spot urine samples. Cadmium levels were evaluated in quintiles (Q). MetS was defined by National Cholesterol Education Program's Adult Treatment Panel III report criteria. Prevalence odds ratios (OR) and 95% confidence intervals (CI) were calculated using multivariable logistic regression accounting for complex survey design, while adjusting for potential confounders and stratifying by sex and smoking status. Results: In the overall study population, there was a marginal inverse association between urinary cadmium and MetS (adj. OR for Q5 versus Q1: 0.7; 95% CI: 0.5–1.0). Sex stratified models were similar. When examining individual components of MetS, participants with higher levels of urinary cadmium had decreased odds of abdominal obesity (adj. OR for Q5 versus Q1 0.4; 95% CI: 0.3–0.6), but increased odds for low HDL (adj. OR for Q5 versus Q1 2.1; 95% CI: 1.4–3.1). Among current smokers, higher urinary cadmium was associated with increased odds of MetS, hypertension, and low HDL even after accounting for serum cotinine—a marker of smoking intensity. Conclusions: Higher levels of urinary cadmium, a marker of long term exposure, were not associated with an increased risk of MetS in the overall study population. However, higher urine cadmium was associated with altered MetS components. Current smokers were the most vulnerable group, with higher long-term cadmium exposure being associated with increased risk of MetS, low HDL, and hypertension. Keywords: Cadmium, Metabolic syndrome, Obesity, Lipids, Hypertension, Hyperglycemiahttp://www.sciencedirect.com/science/article/pii/S0160412018302794
spellingShingle Nudrat Noor
Geng Zong
Ellen W. Seely
Marc Weisskopf
Tamarra James-Todd
Urinary cadmium concentrations and metabolic syndrome in U.S. adults: The National Health and Nutrition Examination Survey 2001–2014
Environment International
title Urinary cadmium concentrations and metabolic syndrome in U.S. adults: The National Health and Nutrition Examination Survey 2001–2014
title_full Urinary cadmium concentrations and metabolic syndrome in U.S. adults: The National Health and Nutrition Examination Survey 2001–2014
title_fullStr Urinary cadmium concentrations and metabolic syndrome in U.S. adults: The National Health and Nutrition Examination Survey 2001–2014
title_full_unstemmed Urinary cadmium concentrations and metabolic syndrome in U.S. adults: The National Health and Nutrition Examination Survey 2001–2014
title_short Urinary cadmium concentrations and metabolic syndrome in U.S. adults: The National Health and Nutrition Examination Survey 2001–2014
title_sort urinary cadmium concentrations and metabolic syndrome in u s adults the national health and nutrition examination survey 2001 2014
url http://www.sciencedirect.com/science/article/pii/S0160412018302794
work_keys_str_mv AT nudratnoor urinarycadmiumconcentrationsandmetabolicsyndromeinusadultsthenationalhealthandnutritionexaminationsurvey20012014
AT gengzong urinarycadmiumconcentrationsandmetabolicsyndromeinusadultsthenationalhealthandnutritionexaminationsurvey20012014
AT ellenwseely urinarycadmiumconcentrationsandmetabolicsyndromeinusadultsthenationalhealthandnutritionexaminationsurvey20012014
AT marcweisskopf urinarycadmiumconcentrationsandmetabolicsyndromeinusadultsthenationalhealthandnutritionexaminationsurvey20012014
AT tamarrajamestodd urinarycadmiumconcentrationsandmetabolicsyndromeinusadultsthenationalhealthandnutritionexaminationsurvey20012014